IP Library Granted Patent US 11,633,461
Granted Patent B2
US 11,633,461 · App. 17/232,509 · Granted Apr 25, 2023

Enzymes and methods for cleaving n-glycans from glycoproteins

Inventors: Daniel Garrido (Santiago, CL); J. Bruce German (Davis, CA); Carlito B. Lebrilla (Davis, CA); David A. Mills (Davis, CA)
Assignee: The Regents of the University of California
A61K38/47A23C9/1216A23L2/52A23L33/195A61K31/715A61K35/741A61K38/40C07K14/79C12N9/2402C12N9/2497C12P19/04C12P21/005A61K38/00C12Y302/01096Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,633,461
App. No.
17/232,509
Granted
Apr 25, 2023
Kind
B2
Abstract

Provided herein are deglycosylating enzymes that remove a broad range of N-glycans from N-glycosylated proteins. Further provided are methods of recombinantly producing and expressing the deglycosylating enzymes. The presently described deglycosylating enzymes can be used to produce free glycans for characterization, and for prebiotic and immunostimulatory uses. In addition, the presently described deglycosylating enzymes can be used to produce deglycosylated proteins for characterization, to improve digestion, and to reduce immunogenicity.

Claims (23)

1. A composition comprising:

(i) a recombinant polypeptide comprising a sequence at least 80% identical to SEQ ID NO:4 or SEQ ID NO:5 wherein said polypeptide can cleave high mannose, complex, and hybrid N-glycans from a glycoprotein and wherein the polypeptide lacks a transmembrane domain; and

(ii) a glycoprotein, wherein the glycoprotein comprises a high mannose, complex, or hybrid N-glycan.

2. The composition of claim 1 , wherein the recombinant polypeptide comprises a sequence at least 80% identical to SEQ ID NO:4.

3. The composition of claim 1 , wherein the recombinant polypeptide comprises a sequence at least 80% identical to SEQ ID NO:5.

4. The composition of claim 1 , wherein the recombinant polypeptide comprises a sequence at least 95% identical to at least one of SEQ ID Nos: 6-20.

5. The composition of claim 1 , wherein the recombinant polypeptide comprises one of SEQ ID Nos: 6-20.

6. The composition of claim 1 , wherein the glycoprotein is selected from the group consisting of: lactoferrin, whey, and immunoglobulin.

7. The composition of claim 1 , wherein the N-glycan comprises core fucosylation, terminal fucosylation, or terminal sialylation.

8. The composition of claim 1 , wherein the polypeptide is a transmembrane protein in a cell membrane in a cell.

9. The composition of claim 1 , wherein the glycoprotein comprises a high mannose N-glycan.

10. The composition of claim 1 , wherein the glycoprotein comprises a complex N-glycan.

11. The composition of claim 1 , wherein the glycoprotein comprises a hybrid N-glycan.

12. A composition comprising a recombinant cell expressing a recombinant polypeptide comprising a sequence at least 80% identical to SEQ ID NO:4 or SEQ ID NO:5, wherein said polypeptide can cleave high mannose, complex, and hybrid N-glycans from a glycoprotein and wherein the polypeptide lacks a transmembrane domain.

13. The composition of claim 12 , wherein the recombinant polypeptide comprises a sequence at least 95% identical to SEQ ID NO:4.

14. The composition of claim 12 , wherein the recombinant polypeptide comprises SEQ ID NO:5.

15. The composition of claim 12 , wherein the recombinant polypeptide comprises a sequence at least 95% identical to SEQ ID NO:5.

16. The composition of claim 12 , wherein the recombinant polypeptide comprises SEQ ID NO:5.

17. The composition of claim 12 , wherein the recombinant polypeptide comprises a sequence at least 95% identical to at least one of SEQ ID Nos: 6-20.

18. The composition of claim 12 , wherein the recombinant polypeptide comprises the recombinant polypeptide comprises one of SEQ ID Nos: 6-20.

19. The composition of claim 12 , wherein the recombinant cell is an E. coli cell.

20. The composition of claim 12 , further comprising a glycoprotein comprises a high mannose, complex, or hybrid N-glycan.

21. The composition of claim 12 , wherein the recombinant cell is a bacterial cell, a yeast cell or a mammalian cell.

Continuity (7)
Continuation 16871811 · May 11, 2020
Continuation 16559333 · Sep 3, 2019
Division 16058898 · Aug 8, 2018
Continuation 15079949 · Mar 24, 2016
Continuation 14378190
Provisional Application 61598593 · Feb 14, 2012
Related Publication 20210308235A1 · Oct 7, 2021